Shinkyo J. Yoon
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 111 publications
Corrigendum to "Enhanced prognostic score for breast cancer brain metastases incorporating contemporary clinical features and leptomeningeal disease: development and validation" [The Breast 88 (2026) 104826].
Journal: Breast (Edinburgh, Scotland)
Published: July 11, 2026
Enhanced prognostic score for breast cancer brain metastases incorporating contemporary clinical features and leptomeningeal disease: Development and validation.
Journal: Breast (Edinburgh, Scotland)
Published: April 08, 2026
Atezolizumab and bevacizumab plus chemotherapy versus chemotherapy in non-small cell lung cancer after tyrosine kinase inhibitor failure.
Journal: Therapeutic advances in medical oncology
Published: December 04, 2025
Molecular epidemiology and outcomes of EGFR exon 20 insertion in Korean patients with non-small cell lung cancer.
Journal: Translational lung cancer research
Published: November 30, 2025
Review: Understanding cattle social behaviour in modern penned production systems with AI technology: Are we tracking welfare indicators?
Journal: Animal : an international journal of animal bioscience
Published: October 13, 2025
Vabametkib Treatment in Refractory Glioblastoma: A Case Report.
Journal: JCO precision oncology
Published: October 09, 2025
Exon-level TP53 alterations and PD-L1 expression identified by pretreatment NGS stratify survival in EGFR-mutant non-small cell lung cancer treated with first-line osimertinib.
Journal: Translational lung cancer research
Published: July 30, 2025
Efficacy and Safety of Lenvatinib Plus Everolimus in Metastatic Renal Cell Carcinoma after Immune Checkpoint and VEGFR Tyrosine Kinase Inhibitors Treatment.
Journal: Cancer research and treatment
Published: June 17, 2025
Body composition and immunotherapy outcomes in patients with advanced urothelial carcinoma.
Journal: BMC cancer
Published: June 16, 2025
Bevacizumab plus Erlotinib in Advanced Solid Cancers with Krebs Cycle Gene Mutations: A Multicenter Phase II Study (BRISK; KCSG AL22-16).
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 09, 2025
State-of-the-Art Imaging in Antibody-Drug Conjugate Treatment for Advanced Bladder Cancer.
Journal: Korean journal of radiology
Published: April 08, 2025
Molecular and Clinical characteristics of ROS1 Fusion Variants in ROS1-rearranged Cancers: A Defined Role of Fusion Partners and Breakpoints of ROS1.
Journal: European journal of cancer (Oxford, England : 1990)
Published: February 27, 2025
Last Updated: 09/26/2026